Zouaoui S, Rigau V, Mathieu-Daudé H, Darlix A, Bessaoud F, Fabbro-Peray P, Bauchet F, Kerr C, Fabbro M, Figarella-Branger D, Taillandier L, Duffau H, Trétarre B, Bauchet L
Département de neurochirurgie, hôpital Gui-de-Chauliac, CHU de Montpellier, 80, avenue Augustin-Fliche, 34295 Montpellier cedex 5, France.
Neurochirurgie. 2012 Feb;58(1):4-13. doi: 10.1016/j.neuchi.2012.01.004. Epub 2012 Mar 3.
This work aimed at prospectively record all primary central nervous system tumor (PCNST) cases in France, for which histological diagnosis was available. The objectives were to (i) create a national database and network to perform epidemiological studies, (ii) implement clinical and basic research protocols, and (iii) harmonize the health care of patients affected by PCNST.
The methodology is based on a multidisciplinary national network already established by the French Brain Tumor DataBase (FBTDB) (Recensement national histologique des tumeurs primitives du système nerveux central [RnhTPSNC]), and the active participation of the Scientific Societies involved in neuro-oncology in France.
From 2004 to 2009, 43,929 cases of newly diagnosed and histologically confirmed PCNST have been recorded. Histological diagnoses included gliomas (42,4%), all other neuroepithelial tumors (4,4%), tumors of the meninges (32,3%), nerve sheath tumors (9,2%), lymphomas (3,4%) and others (8,3%). Cryopreservation was reported for 9603 PCNST specimens. Tumor resections were performed in 78% cases, while biopsies accounted for 22%. Median age at diagnosis, sex, percentage of resections and number of cryopreserved tumors were detailed for each histology, according to the WHO classification.
DISCUSSION/CONCLUSION: Many current applications and perspectives for the FBTDB are illustrated in the discussion. To our knowledge, this work is the first database in Europe, dedicated to PCNST, including clinical, surgical and histological data (with also cryopreservation of the specimens), and which may have major epidemiological, clinical and research implications.
本研究旨在前瞻性记录法国所有有组织学诊断结果的原发性中枢神经系统肿瘤(PCNST)病例。目标是:(i)创建一个国家数据库和网络以开展流行病学研究;(ii)实施临床和基础研究方案;(iii)协调原发性中枢神经系统肿瘤患者的医疗护理。
该方法基于法国脑肿瘤数据库(FBTDB)(原发性中枢神经系统肿瘤全国组织学普查 [RnhTPSNC])已经建立的多学科国家网络,以及法国参与神经肿瘤学的科学学会的积极参与。
2004年至2009年期间,共记录了43929例新诊断且经组织学确诊的原发性中枢神经系统肿瘤病例。组织学诊断包括胶质瘤(42.4%)、所有其他神经上皮肿瘤(4.4%)、脑膜肿瘤(32.3%)、神经鞘瘤(9.2%)、淋巴瘤(3.4%)和其他(8.3%)。9603例原发性中枢神经系统肿瘤标本进行了冷冻保存。78%的病例进行了肿瘤切除,而活检占22%。根据世界卫生组织分类,详细列出了每种组织学类型的诊断时中位年龄、性别、切除百分比和冷冻保存肿瘤数量。
讨论/结论:讨论中阐述了法国脑肿瘤数据库目前的许多应用和前景。据我们所知,这项工作是欧洲首个专门针对原发性中枢神经系统肿瘤的数据库,包括临床、手术和组织学数据(还包括标本的冷冻保存),可能具有重大的流行病学、临床和研究意义。